Explorer les evidences

17,6 %Sixty-six (17.6%) patients experienced virological failure (VL ≥1000 copies/ml) after 36 months of antiretroviral treatment in Cameroon.

CamerounVIH/sidapublié 2013Journal of the International AIDS Societyeurope_pmcdocument de 4 observations

67,7 %Viral suppression in the ART 48-60 group was 67.7% overall.

CamerounVIH/sidapublié 2018EClinicalMedicineeurope_pmcdocument de 6 observations

13 %Among HIV-1 protease (PR) sequences from drug-naïve Cameroonians, the secondary PI resistance-associated mutation 77I was present in 13% of strains.

CamerounVIH/sidapublié 2002Journal of Clinical MicrobiologyOpenAlexdocument de 12 observations

38 %Among 110 HIV-1-infected, drug-naïve Cameroonians, dual and triple PI resistance-associated substitutions were found in 38% of all strains.

CamerounVIH/sidapublié 2002Journal of Clinical MicrobiologyOpenAlexdocument de 12 observations

30 %Among classifiable protease (PR) sequences from HIV-1-infected, drug-naïve Cameroonians, 30% had dual and triple PI resistance-associated substitutions.

CamerounVIH/sidapublié 2002Journal of Clinical MicrobiologyOpenAlexdocument de 12 observations

11 %The prevalence of the 10I substitution in protease sequences was 11% (6/57) among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublié 2011AIDS Research and Human RetrovirusesOpenAlexdocument de 24 observations

There was a significant trend towards a positive change in waist-to-hip ratio with increasing duration of highly active antiretroviral therapy (HAART) in HIV-infected Cameroonians.

CamerounVIH/sidapublié 2013Diabetes & metabolismeurope_pmcdocument de 12 observations

2 %The prevalence of the 312Q substitution in reverse transcriptase sequences was 2% among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublié 2011AIDS Research and Human RetrovirusesOpenAlexdocument de 24 observations

90 %CRF01_AE predominates (>90%) in Thailand and Vietnam.

CamerounVIH/sidapublié 2009AIDS Research and Human RetrovirusesOpenAlexdocument de 3 observations

9,4 %Adult HIV prevalence (≥18 years) was 9.4% in 2012 (210/2271 adults).

CamerounVIH/sidaobservé 2012publié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

-0,59 SMDHIV infection was associated with lower high-density lipoprotein with a standardized mean difference of -0.59.

Camerounhigh-density lipoprotein · VIH/sidapublié 2013International journal of epidemiologyeurope_pmcdocument de 10 observationsDOI 10.1093/ije/dyt198

142 isolatesAmong 142 HIV-1 isolates from antiretroviral-naive patients, 4 belonged to group O and 138 belonged to group M.

CamerounVIH/sidapublié 2000Journal of Clinical MicrobiologyOpenAlexdocument de 19 observations

0,39 SMDAmong HIV+ individuals, antiretroviral therapy use was associated with higher high-density lipoprotein with a standardized mean difference of 0.39.

Camerounhigh-density lipoprotein · VIH/sidapublié 2013International journal of epidemiologyeurope_pmcdocument de 10 observationsDOI 10.1093/ije/dyt198

20 %In 2010, 20% of 40 ART sites in Cameroon attained the target for patient retention on first line ART (target ≥ 70%).

CamerounVIH/sidaobservé 2010publié 2012PLoS ONEOpenAlexdocument de 5 observationsDOI 10.1371/journal.pone.0036777

89 %The prevalence of the 335C/D substitution in reverse transcriptase sequences was 89% among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublié 2011AIDS Research and Human RetrovirusesOpenAlexdocument de 24 observations

324 ART defaultersA total of 324 ART defaulters were identified and linked back to care.

CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

4,8 daysHIV-positive adult participants with CD4 >550 worked 4.8 more days during the past month than those with CD4 <350.

CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

69,7 %Among 76 patients followed-up at endpoint, 69.7% had viremia <40 copies/ml.

CamerounVIH/sidaobservé 2009-2011publié 2013PLoS ONEOpenAlexdocument de 8 observationsDOI 10.1371/journal.pone.0072680

0,7 %The L33F mutation was identified in 0.7% of the 142 HIV-1 isolates in the protease gene.

CamerounVIH/sidapublié 2000Journal of Clinical MicrobiologyOpenAlexdocument de 19 observations

4,1 %The vertical transmission rate was 4.1% (34/837) among infants born to mothers on short-course ART.

CamerounVIH/sidaobservé November 2007 to October 2010publié 2019Paediatrics and international child healthPubMeddocument de 7 observations

71 %Versions 1.0, 1.0+, and 1.5 detected 71, 100, and 100% of the subtype E-infected samples from patients, respectively.

CamerounVIH/sidapublié 1999Journal of Clinical MicrobiologyOpenAlexdocument de 6 observationsDOI 10.1128/jcm.37.1.110-116.1999

26,4 %Among 458 patients who initiated antiretroviral therapy in rural district hospitals in Cameroon between 2006 and 2008, 121 (26.4%) were classified at WHO clinical stage 4.

CamerounVIH/sidaobservé 2006-2008publié 2010Tropical medicine & international health : TM & IHeurope_pmcdocument de 7 observations

96 patientsPlasma samples from 96 patients infected with various subtypes of HIV-1 were tested, including 55 infected with subtype A, 9 with subtype B, 21 with subtype C, 2 with subtype D, 7 with subtype E, and 2 with subtype G.

CamerounVIH/sidapublié 1999Journal of Clinical MicrobiologyOpenAlexdocument de 6 observationsDOI 10.1128/jcm.37.1.110-116.1999

1,6 %Phylogenetic analysis of the gp41 region of 123 HIV-1-seropositive specimens from Cameroon showed that 2 (1.6%) remained unclassifiable.

CamerounVIH/sidapublié 2000AIDS Research and Human RetrovirusesOpenAlexdocument de 7 observations

4 %Clades D and CRF37_cpx each accounted for 4% of the studied HIV infections in Cameroonian blood donors.

CamerounVIH/sidapublié 2013Virology JournalOpenAlexdocument de 7 observationsDOI 10.1186/1743-422x-10-29